Lisa K. Miller, an officer of LifeStance Health Group, Inc., filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 14,663 shares of LifeStance common stock on NASDAQ.

Key Highlights

  • Seller: Lisa K. Miller, identified in the filing as an officer of LifeStance Health Group, Inc.
  • Shares proposed for sale: 14,663 shares of common stock, with an aggregate market value of $215,252.84, according to the filing.
  • Source of shares: The securities were acquired on November 10, 2026, through a restricted stock vesting transaction from the issuer, with compensation listed as the nature of payment.
  • Approximate sale date: November 11, 2026, through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917.
  • Shares outstanding: The filing states 380,190,724 shares of common stock outstanding.
  • Rule 10b5-1 plan: The filing indicates a plan adoption date of May 7, 2026.
  • Prior sales in the last three months: The filing reports nothing to report under the past three months' sales section.

LifeStance Officer Discloses Proposed Common Stock Sale Under Rule 144

According to the Form 144 filing submitted to the U.S. Securities and Exchange Commission on November 12, 2026, Lisa K. Miller, an officer of LifeStance Health Group, Inc. (NASDAQ:LFST), proposed to sell 14,663 shares of the company's common stock. The filing lists an aggregate market value of $215,252.84 for the shares to be sold. The broker identified for the transaction is Fidelity Brokerage Services LLC.

The filing discloses that the 14,663 shares were acquired on November 10, 2026, through a restricted stock vesting transaction from the issuer, with the nature of payment listed as compensation. The approximate date of sale is listed as November 11, 2026. At the time of the notice, the filing states that 380,190,724 shares of LifeStance common stock were outstanding.

The filing further indicates that the proposed sale is being conducted pursuant to a written trading plan adopted on May 7, 2026, consistent with Rule 10b5-1 under the Exchange Act. The notice was signed by Daniel Tucci, described as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Lisa Miller. No sales by Miller during the prior three months were reported in the filing.

What Was Disclosed

LifeStance Health Group officer Lisa K. Miller filed a Form 144 notice proposing the sale of 14,663 shares of common stock, valued at $215,252.84 in aggregate, with the shares originating from a restricted stock vesting event on November 10, 2026.